Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $2.27B | $2.14B | +5.82% |
Cost of Revenue | $1.47B | $1.42B | +3.49% |
Gross Profit | $800.1M | $724.9M | +10.37% |
Operating Income | $428.3M | $410.3M | +4.39% |
Net Income | $361.6M | $362.6M | -0.28% |
EPS (Basic) | $5.00 | $4.96 | +0.81% |
EPS (Diluted) | $4.97 | $4.91 | +1.22% |
R&D Expense | $52.5M | $50.6M | +3.75% |
SG&A Expense | $286.6M | $253.2M | +13.19% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $4.11B | $3.68B | +11.72% |
Current Assets | $1.82B | $1.55B | +17.59% |
Total Liabilities | $1.05B | $923M | +14.23% |
Current Liabilities | $635.4M | $516.5M | +23.02% |
Stockholders' Equity | $3.05B | $2.75B | +10.88% |
Cash & Equivalents | $628.5M | $490.9M | +28.03% |
Long-Term Debt | $202.7M | $202.6M | +0.05% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $503.7M | $463.3M | +8.72% |
Investing Cash Flow | $-209.8M | $-273.9M | +23.40% |
Financing Cash Flow | $-173.4M | $-553.7M | +68.68% |
Share Buybacks | $134M | $506.5M | -73.54% |
D&A | $124.4M | $114.7M | +8.46% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Gross Margin | 35.3% | 33.8% | +1.46% |
Operating Margin | 18.9% | 19.1% | -0.26% |
Net Margin | 15.9% | — | — |
ROE | 11.8% | — | — |
ROA | 8.8% | — | — |
Current Ratio | $2.87 | — | — |
Debt to Equity | $0.346 | — | — |
Other companies in Life Sciences Tools & Services